WALTHAM, Mass. and BOULDER, Colo., Oct. 24, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined ...
Agendia to Present Five Posters Demonstrating the Expanding Clinical Utility of MammaPrint + BluePrint at the 2025 San Antonio Breast Cancer Symposium New data from the ongoing FLEX Study highlight ...
SAN JOSE, Calif., Oct. 23, 2025 /PRNewswire/ -- BridGene Biosciences, Inc., a leader in the discovery of small molecule drugs for traditionally "hard-to-drug" targets, announced today that three ...
Twelve years ago, I heard the words no one ever wants to hear: “you have cancer.” More specifically, stage 3 breast cancer. I had watched my mother go through her own cancer battle in the 1970s, when ...
At this year’s AACR 2025 (Chicago, IL, USA; 25–30 April), the annual meeting of the American Association for Cancer Research, we picked out our favourite posters from the conference and spoke to their ...
Zentalis Pharmaceuticals, Inc. announced that an abstract has been accepted for a poster presentation at the 2025 American Society of Clinical Oncology Annual Meeting, scheduled for May 30 to June 3 ...
Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roof for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback